Breast lumps epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 12: Line 12:


===Prevalence===
===Prevalence===
*The prevalence of benign breast disease is approximately 68% among all breast disease
*The prevalence of benign breast disease is approximately 68% among all breast diseases<ref name="MRao2016">{{cite journal|last1=M|first1=Dr. Vijayalakshmi|last2=Rao|first2=Dr. J Yadigiri|last3=Shekar|first3=Dr. T.Y.|last4=Balakrishnan|first4=Dr. Shobha|last5=M|first5=Dr. Divya|last6=K|first6=Dr. Sameera|last7=N|first7=Dr. Alekya|last8=JVNK|first8=Dr. Aravind|title=Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases|journal=IOSR Journal of Dental and Medical Sciences|volume=15|issue=08|year=2016|pages=32–36|issn=22790861|doi=10.9790/0853-1508083236}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*Approximately 605 of benign breast diseases occur in left breast and 40% in the right breast
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
*100% of definite palpable lumps are characteristics of fibroadenoma,phyllodes tumor and adenomyoepithelioma
*64% of lumps located in upper outer quadrant,26% of lumps in lower outer quadrant, 10% of lumps in upper inner quadrant


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===

Revision as of 20:01, 19 December 2018

Breast lumps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Breast lumps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Breast lumps epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Breast lumps epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Breast lumps epidemiology and demographics

on Breast lumps epidemiology and demographics

Breast lumps epidemiology and demographics in the news

Blogs on Breast lumps epidemiology and demographics

Directions to Hospitals Treating Breast lumps

Risk calculators and risk factors for Breast lumps epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence rate of benign breast disease is not clear due to the fact that breast lumps do not consider as life threatening problems[1]
  • Women who receive medical therapies or surgeries mostly come into account
  • Particular detection rate is not known and estimated

Prevalence

  • The prevalence of benign breast disease is approximately 68% among all breast diseases[2]
  • Approximately 605 of benign breast diseases occur in left breast and 40% in the right breast
  • 100% of definite palpable lumps are characteristics of fibroadenoma,phyllodes tumor and adenomyoepithelioma
  • 64% of lumps located in upper outer quadrant,26% of lumps in lower outer quadrant, 10% of lumps in upper inner quadrant

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. Goehring C, Morabia A (1997). "Epidemiology of benign breast disease, with special attention to histologic types". Epidemiol Rev. 19 (2): 310–27. PMID 9494790.
  2. M, Dr. Vijayalakshmi; Rao, Dr. J Yadigiri; Shekar, Dr. T.Y.; Balakrishnan, Dr. Shobha; M, Dr. Divya; K, Dr. Sameera; N, Dr. Alekya; JVNK, Dr. Aravind (2016). "Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases". IOSR Journal of Dental and Medical Sciences. 15 (08): 32–36. doi:10.9790/0853-1508083236. ISSN 2279-0861.

Template:WH Template:WS